Rhinomaris, spray 0.1% 15 ml

Pharmacotherapeutic group

An anticongestive agent – vasoconstrictor (alpha-adrenomimetic).

ATX CODE: R01AA07

Pharmacokinetics

In topical administration it is practically not absorbed; plasma concentrations are so low that they cannot be determined by modern analytical methods.

Pharmacological properties

Rinomaris is a drug for intranasal use.

Xylometazoline has an alpha-adrenomimetic action: it induces constriction of the blood vessels of the nasal mucosa, thus eliminating nasopharyngeal mucosa edema and hyperemia. Facilitates nasal breathing in rhinitis. In therapeutic concentrations it does not irritate nasal mucosa, does not cause hyperemia. Its effect begins within a few minutes after application and lasts for 12 hours.

The sterilized sea water which is part of Rinomaris helps maintain normal physiologic state of the nasal mucosa, thinning of mucus and normalization of its production in the bocalytic cells of the nasal cavity mucosa.

Micronutrients improve the function of the atrial fibrillation epithelium which helps reduce adverse local reactions such as irritation and/or dryness of the nasopharyngeal mucosa.

Indications

Acute respiratory diseases with rhinitis (runny nose) phenomena;

Allergic rhinitis (pollinosis);

Sinusitis;

Eustachitis;

/p>

otitis media (to reduce nasopharyngeal mucosal edema);

Physician preparation for diagnostic manipulations in the nasal passages.

Active ingredient

How to take, the dosage

Rinomaris®, nasal spray, 0.1%

Children over 6 years of age and adults: 1 injection in each nostril 2 to 3 times a day.

The drug should not be used more than 4 times a day and the course of therapy should be 5-7 days.

Special Instructions

The nasal passages should be cleaned before use.

Rinomaris® should not be used for prolonged periods, e.g. in chronic rhinitis.

Impact on driving and operating machinery

Xylomethasoline in doses greater than those recommended may affect the ability to operate vehicles or equipment.

Contraindications

Artial hypertension, tachycardia, marked atherosclerosis, glaucoma, atrophic rhinitis, thyrotoxicosis, brain surgery (in anamnesis), children under 6 years (for 0.1% solution), hypersensitivity to the drug components.

Side effects

In frequent and/or prolonged use – irritation and/or dryness of the nasopharyngeal mucosa, burning, tingling, sneezing, hypersecretion, nasal mucosa edema.

Perception of palpitations, tachycardia, arrhythmias, increased BP, headache, vomiting, insomnia, visual disturbances; with long-term use in high doses – depression.

Overdose

Symptoms: intensification of side effects.

Treatment: conduct symptomatic therapy.

Pregnancy use

Similarities